| A | |
| AML | acute myeloid leukaemia |
| APCs | antigen presenting cells |
| ARG1 | arginase-1 |
| B | |
| BAG6 | large proline-rich protein BAG6 |
| C | |
| CCL2 | C-C motif chemokine ligand 2 |
| CCRs | chemokine receptors |
| CLL | chronic lymphocytic leukemia |
| CRC | colorectal cancer |
| D | |
| DAMPs | damage-associated molecular patterns |
| DC | dendritic cells |
| E | |
| eTreg | effector Treg |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial mesenchymal transition |
| EOC | epithelial ovarian cancer |
| ECM | extracellular matrix |
| EVs | Extracellular Vesicles |
| F | |
| FAS-L | tumor necrosis factor ligand superfamily, member 6 |
| FDA | Food and Drug Administration |
| G | |
| LGALS9 | galectin 9 |
| GBM | glioblastoma multiforme |
| gp100 | glycoprotein 100 |
| H | |
| HNSCC | head and neck squamous |
| HDGF | hepatoma-derived growth factor |
| HSP70 | heat shock protein 70 |
| HA | hyaluronan |
| HA | hyaluronic acid |
| I | |
| iDC | Immature DCs |
| ICP | immune checkpoint proteins |
| ICD | immunogenic cell death |
| IFN-β | interferon-β |
| L | |
| LGALS9 | galectin 9 |
| LPS | lipopolysaccharide |
| lnc | long non-coding |
| LNs | lymph nodes |
| CD107a/LAMP1 | lysosomal-associated membrane protein 1 |
| M | |
| MEKK2 | MEK kinase 2 |
| MART1 | melanoma-associated antigen 3-MAGE-A3 |
| MIF | macrophage migration inhibitory factor |
| MUC1 | mucin-1 |
| MM | multiple myeloma |
| MDSCs | Myeloid-derived suppressor cells |
| N | |
| NK | natural killer |
| NKG2DL | NKG2D ligand |
| NPM1 | nucleophosmin |
| P | |
| PDAC | pancreatic ductal adenocarcinoma |
| PDCD4 | programmed cell death factor 4 |
| PD1 | programmed death 1 |
| PD-L1 | programmed death ligand 1 |
| PGE2 | prostaglandin E2 |
| PLP2 | proteolipid protein 2 |
| R | |
| RFXAP | regulatory factor X-associated protein |
| Tregs | regulatory T cells |
| S | |
| SIRPalpha | signal regulatory protein alpha |
| SCLC | small cell lung cancer |
| sNMase | neutral sphingomyelinase |
| nSMase | sphingomyelinase |
| SPHK1 | sphingosine kinase-1 |
| SPHK1 | sphingosine kinase 1 |
| SCC | squamous cell carcinoma |
| T | |
| TCR | T-cell receptor |
| TERF1 | telomeric repeat binding factor 1 |
| TβRII | TGF-β type II receptor |
| TLR4 | Toll-like receptor 4 |
| TGF-β | transforming growth factor β |
| SMAD3 | transforming growth factor-beta signaling protein 3 |
| TAAs | tumor associated antigens |
| TME | Tumor Microenvironment |
| TNF | tumor necrosis factor |
| TRAIL | tumor necrosis factor (TNF)-related apoptosis-inducing ligand |
| TAMs | tumor-associated macrophages |
| TEVs | tumor-derived EVs |